A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma

NCT05160805 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Open Angle Glaucoma

Interventions

DRUG: ONL1204 Ophthalmic solution (Dose A)
DRUG: ONL1204 Ophthalmic solution (Dose B)
PROCEDURE: Sham procedure

Sponsor

ONL Therapeutics